Esther W. Barrow - Concepedia

Author

Esther W. Barrow

Oklahoma State University

Also Known As

E. Barrow, E. W. Barrow, Esther Barrow, Esther W Barrow, Esther W. Barrow

Publications

576

Citations

H-Index

Concepts

All Affiliations

Oklahoma State University Southern Research Institute

About

Esther W. Barrow is an author at Oklahoma State University specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	291
2	Biochemistry	8	8	219
3	Natural Sciences	4	4	119
4	Health Sciences	2	2	135
5	Engineering	1	1	33

Esther W. Barrow

Publications

515

Citations

H-Index

Page 1

	Year	Citations
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis Ze‐Qi Xu, William W. Barrow, William J. Suling, Bioorganic & Medicinal Chemistry Pulmonary TuberculosisAntiviral CompoundHealth SciencesMedicineMycobacterium Tuberculosis	2004	103
Antimycobacterial Activities of 2,4-Diamino-5-Deazapteridine Derivatives and Effects on Mycobacterial Dihydrofolate Reductase William J. Suling, Lainne E. Seitz, Vibha Pathak, Antimicrobial Agents and Chemotherapy	2000	73
Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase William J. Suling, Robert C. Reynolds, Esther W. Barrow, Journal of Antimicrobial Chemotherapy Antimicrobial ChemotherapyPharmaceutical ChemistryMycobacterium Avium ComplexDrug ResistanceM. Tuberculosis	1998	57
Inhibition of Antibiotic-Resistant <i>Staphylococcus aureus</i> by the Broad-Spectrum Dihydrofolate Reductase Inhibitor RAB1 Christina R. Bourne, Esther W. Barrow, Richard A. Bunce, Antimicrobial Agents and Chemotherapy Bioorganic ChemistryAntibiotic AdjuvantMolecular BiologyAntimicrobial ChemotherapyChemical Biology	2010	44
Crystal Structure of <i>Bacillus anthracis</i> Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity Christina R. Bourne, Richard A. Bunce, Philip C. Bourne, Antimicrobial Agents and Chemotherapy	2009	43
Functional Cloning of <i>Bacillus anthracis</i> Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim Esther W. Barrow, Philip C. Bourne, William W. Barrow Antimicrobial Agents and Chemotherapy Sterne Dhfr GeneTmp ResistanceBiosynthesisEngineeringBiochemistry	2004	33
In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant <i>Bacillus anthracis</i> Esther W. Barrow, Jürg Dreier, Stefan Reinelt, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug ResistanceAntimicrobial Therapy	2007	32
Antimycobacterial activity of 2-methyl-adenosine Esther W. Barrow Journal of Antimicrobial Chemotherapy	2003	32
Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis Baskar Nammalwar, Richard A. Bunce, K. Darrell Berlin, European Journal of Medicinal Chemistry Biological ActivityBioorganic ChemistryBiochemistryNatural SciencesAntibacterial Agent	2012	30
The metabolism of 2-methyladenosine in Mycobacterium smegmatis Chih‐Kuang Chen, Esther W. Barrow, Paula W. Allan, Microbiology Mycobacterium SmegmatisBiosynthesisCellular EnzymologyBiochemistryAdenosine Kinase	2002	18

Page 1